Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours [Phase 1, Phase 2]
Phase I/II clinical trial evaluating the safety and tolerability of LiPlaCis in patients with advanced or refractory tumours; trial complete…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Ultralow Versus Standard Pneumoperitoneum Pressure [NA]
Clinical trial update for ultralow versus standard pneumoperitoneum pressure in prostate cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy [Phase 2]
Phase 2 trial evaluating sorafenib in combination with docetaxel for prostate cancer that progressed after hormone therapy has completed wit…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases [NA]
Clinical trial update for Radium 223 in castration-resistant prostate cancer with bone metastases; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent [Phase 4]
A Phase 4 trial compared cabazitaxel to switching to another AR-targeted agent (enzalutamide or abiraterone) in metastatic castration-resist…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic [Phase 2]
Phase 2 trial evaluating treatment of metastatic castration-resistant prostate cancer using circulating tumor cell kinetics.
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy [Phase 2]
Phase 2 trial update on soy derivatives for managing hot flashes in men undergoing androgen deprivation therapy for prostate cancer; study t…
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 [Phase 2]
Phase 2 trial assessing biomarker-driven therapy with nivolumab and ipilimumab for metastatic hormone-resistant prostate cancer expressing A…
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes [Phase 2]
Phase 2 BrUOG 337 trial evaluating olaparib before radical prostatectomy in advanced prostate cancer was terminated; results have been poste…
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: MR Image Guided Therapy in Prostate Cancer [Phase 2]
Phase 2 clinical trial update on MR image-guided therapy for prostate cancer has completed with posted results.
-
FDA approval · 2022-01-28FDA Approved: YONSA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for YONSA (abiraterone acetate) submitted by Sun Pharmaceutical Industries, Inc. under NDA 21030…
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Prostate Cancer Screening Trial Using Imaging
Clinical trial completion for a prostate cancer screening study using imaging; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer [Phase 2]
Phase 2 trial evaluating adjuvant statin therapy in patients after radical prostatectomy for locally advanced prostate cancer completed.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer [NA]
Clinical trial update on stereotactic body radiotherapy (SBRT) for prostate cancer; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC [Phase 3]
Phase 3 study evaluating apalutamide plus androgen deprivation therapy (ADT) versus ADT alone in men with metastatic hormone-sensitive prost…
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC [Phase 3]
Phase 3 trial evaluating apalutamide added to androgen deprivation therapy versus ADT alone in metastatic hormone-sensitive prostate cancer;…
-
FDA approval · 2022-01-13FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for XTANDI (enzalutamide) submitted by Astellas Pharma US, Inc. The action reflects an approval …
-
FDA approval · 2022-01-13FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XTANDI (enzalutamide) submitted by Astellas Pharma US, Inc., resulting in updated labeling for p…
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer [Phase 3]
Phase 3 trial update evaluating decision aids to improve knowledge for patients newly diagnosed with prostate cancer; results have been post…
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment [Phase 2, Phase 3]
Phase 2/3 trial evaluating 68Ga-PSMA PET/CT for detecting prostate cancer recurrence in patients with elevated PSA after initial treatment h…
-
CLINICAL_TRIALS trial_result · 2022-01-06Clinical Trial Update: Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer [Phase 3]
Phase 3 trial investigating external beam radiation therapy with and without hormonal therapy for prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-06Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery [NA]
A clinical trial update reports completion of a study evaluating stereotactic body radiation therapy for high-risk prostate cancer patients …
-
CLINICAL_TRIALS trial_result · 2022-01-05Clinical Trial Update: Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer [Phase 2]
Phase 2 trial evaluating radiolabeled Gallium-68 PSMA PET/CT imaging for detecting prostate cancer has been terminated with results posted.
-
FDA approval · 2022-01-05FDA Approved: ABIRATERONE ACETATE — Original Application (Novugen Pharma (USA) LLC)
FDA approved a generic version of abiraterone acetate from Novugen Pharma (USA) LLC via an Original Application (ANDA) for metastatic castra…
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors completed; results posted.